CBLL.NASDAQCeribell, INC

Form 4: Ceribell CEO Exercises Options, Sells Shares

Sentiment:

Insider Transaction Report


Ceribell's President and CEO, Xingjuan Chao, exercised stock options and subsequently sold 50,000 shares of common stock under a Rule 10b5-1 trading plan.

Summary

  • On November 21, 2025, Xingjuan Chao, President and CEO of Ceribell, Inc., engaged in multiple transactions involving the company's common stock.
  • Exercised options to acquire 25,000 shares of common stock at an exercise price of $2.24 per share.
  • Exercised options to acquire an additional 25,000 shares of common stock at an exercise price of $3.65 per share.
  • Sold a total of 50,000 shares of common stock at a weighted average price of $15.13 per share, with individual transaction prices ranging from $15.00 to $15.20.
  • All reported transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
  • Following these transactions, direct beneficial ownership of common stock remains at 798,135 shares.
  • An additional 369,088 shares are indirectly owned through the ACP 2021 Trust, for which the reporting person is a co-trustee.
  • A previous correction to Forms 4/A filed on September 12, 2025, added 25,000 shares to beneficial ownership due to inadvertently omitted option exercises.

Sentiment

Score: 5

Explanation: Neutral. The filing reports routine insider transactions (option exercise and sale) under a 10b5-1 plan. While a sale by a CEO can sometimes be viewed negatively, the pre-planned nature and the profit realized from option exercises balance the sentiment, indicating a monetization of equity compensation rather than a bearish signal.

Positives

  • The transactions were conducted under a Rule 10b5-1 trading plan, indicating pre-planned sales and potentially mitigating concerns about opportunistic insider selling.
  • The sale price of $15.13 per share is significantly higher than the exercise prices of $2.24 and $3.65, demonstrating a profitable monetization of equity compensation for the CEO.

Negatives

  • A sale of 50,000 shares by the President and CEO, even if pre-planned, could be perceived negatively by some investors as it reduces insider ownership.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing reports routine insider transactions (option exercises and subsequent share sales) and does not provide information that directly relates to broader industry trends or the competitive landscape.

Comparison to Industry Standards

  • This filing is a standard insider transaction report and does not contain information suitable for comparison to global benchmarks, comparable companies, projects, or results.

Stakeholder Impact

  • Shareholders: May view the CEO's sale of shares as a signal, though the 10b5-1 plan mitigates concerns of opportunistic selling. The profit from option exercises could be seen as a positive for executive compensation alignment.

Key Dates

DateDescription
06/10/2021Start date for monthly vesting of certain stock options.
09/12/2025Date of previously filed Forms 4/A correction, adding 25,000 shares from omitted option exercises.
11/21/2025Date of reported stock option exercises and common stock sale.
11/25/2025Signature date of the Form 4 filing.
06/10/2029Expiration date of stock option with exercise price $2.24.
06/10/2031Expiration date of stock option with exercise price $3.65.

Recommendation

hold

This Form 4 filing details a pre-planned insider transaction where the CEO exercised options and sold a portion of the resulting shares. Such transactions, especially under a Rule 10b5-1 plan, are generally considered routine and do not typically signal a fundamental change in the company's outlook. The sale represents a monetization of previously granted equity compensation rather than a bearish signal on the company's future. Therefore, based solely on this filing, a 'hold' recommendation is appropriate as there is no new information to warrant a change in investment thesis.

Keywords

Ceribell Inc., CBLL, Insider Trading, Form 4, Stock Options, Share Sale, CEO, Xingjuan Chao, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.